BRIEF published on 07/16/2026 at 18:05, 3 months 9 days ago PREDILIFE's semi-annual liquidity contract review as of June 30, 2026 Liquidity Transactions Actions PREDILIFE Half-year Review
BRIEF published on 07/02/2026 at 18:05, 3 months 23 days ago Termination of the liquidity contract between PREDILIFE and TSAF Liquidity Contract Termination Euronext Growth TSAF PREDILIFE
BRIEF published on 07/01/2026 at 18:05, 3 months 24 days ago Results of the PREDILIFE General Meeting Capital Artificial Intelligence General Assembly PREDILIFE Resolutions Adopted
BRIEF published on 06/29/2026 at 20:05, 3 months 26 days ago Predilife: Update on the FDA procedure and 2025 financial report FDA Artificial Intelligence Financial Report Judicial Reorganization PREDILIFE
BRIEF published on 06/02/2026 at 08:05, 4 months 23 days ago Predilife: 2025 Review and Advances in Predictive Medicine Cancer Screening 2025 Financial Results Restructuring Strategy FDA Denseerisk Personalized Prediction
BRIEF published on 04/07/2026 at 08:05, 6 months 18 days ago Predilife outlines its strategy to maximize its industrial and financial potential Treasury PREDILIFE MammoRisk Industrial Strategy Risk Prediction
BRIEF published on 03/02/2026 at 19:05, 7 months 23 days ago PREDILIFE is making progress in submitting DenSeeRisk to the FDA FDA PREDILIFE MammoRisk Breast Cancer DenSeeRisk
BRIEF published on 01/16/2026 at 18:05, 9 months 9 days ago PREDILIFE's Half-Yearly Review of Liquidity Contract Liquidity Contract Personalized Medicine PREDILIFE Semi-annual Transactions Financial Economy
BRIEF published on 12/17/2025 at 18:35, 10 months 8 days ago Major validation of the MammoRisk strategy against breast cancer PREDILIFE MammoRisk Breast Cancer Personalized Screening WISDOM Study
BRIEF published on 12/10/2025 at 18:05, 10 months 15 days ago PREDILIFE raises €900,000 Artificial Intelligence Fundraising Convertible Bonds Dilution PREDILIFE
Published on 10/24/2026 at 00:04, 2 days ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 2 days 1 hour ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 2 days 2 hours ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 2 days 8 hours ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/24/2026 at 23:44, 1 day ago EQS-Adhoc: HomeToGo SE: Unauthorized data exfiltration at subsidiary SECRA Bookings GmbH
Published on 10/24/2026 at 14:15, 1 day 10 hours ago Winners of the 2026 INPD Awards Announced, C-Beauty Takes Home Multiple Prestigious Honors
Published on 10/24/2026 at 06:30, 1 day 18 hours ago AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand
Published on 10/23/2026 at 18:55, 2 days 5 hours ago Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 18:00, 2 days 6 hours ago BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL
Published on 10/23/2026 at 20:33, 2 days 4 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 6 hours ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 3 days 6 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 3 days 6 hours ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
